Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014

1
Aarkstore - Herpes Zoster (Shingles) - Pipeline
Review, H2 2014
www.aarkstore.com
2
Summary

• Herpes Zoster (Shingles) - Pipeline Review, H2
  2014, provides an overview of the
• Herpes Zoster (Shingles)s therapeutic pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Herpes Zoster (Shingles),
  complete with comparative analysis at various
• stages, therapeutics assessment by drug target,
  mechanism of action (MoA), route of
• administration (RoA) and molecule type, along
  with latest updates, and featured news and
• press releases. It also reviews key players
  involved in the therapeutic development for
  Herpes
• Zoster (Shingles) and special features on
  late-stage and discontinued projects.

www.aarkstore.com
www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Herpes Zoster
  (Shingles)- The report reviews key pipeline
  products under drug profile section which
  includes, product description, MoA and RD brief,
  licensing and collaboration details other
  developmental activities - The report reviews
  key players involved in the therapeutics
  development for Herpes Zoster (Shingles) and
  enlists all their major and minor projects- The
  report summarizes all the dormant and
  discontinued pipeline projects - A review of the
  Herpes Zoster (Shingles) products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources- Pipeline
  products coverage based on various stages of
  development ranging from pre-registration till
  discovery and undisclosed stages- A detailed
  assessment of monotherapy and combination therapy
  pipeline projects- Coverage of the Herpes Zoster
  (Shingles) pipeline on the basis of target, MoA,
  route of administration and molecule type-
  Latest news and deals relating related to
  pipeline products

www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Herpes Zoster (Shingles)- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Herpes Zoster (Shingles) pipeline
  depth and focus of Indication therapeutics-
  Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline

www.aarkstore.com
5
Table of Contents

• Introduction 6Global Markets Direct
  Report Coverage 6Herpes Zoster (Shingles)
  Overview 7Therapeutics Development 8Pipeline
  Products for Herpes Zoster (Shingles) - Overview
  8Pipeline Products for Herpes Zoster (Shingles)
  - Comparative Analysis 9Herpes Zoster (Shingles)
  - Therapeutics under Development by Companies
  10Herpes Zoster (Shingles) - Pipeline Products
  Glance 12Late Stage Products 12Clinical Stage
  Products 13Early Stage Products 14Unknown Stage
  Products 15Herpes Zoster (Shingles) - Products
  under Development by Companies 16Herpes Zoster
  (Shingles) - Companies Involved in Therapeutics
  Development 17GlaxoSmithKline plc 17

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Herpes Zoster (Shingles), H2 2014 8Number of
  Products under Development for Herpes Zoster
  (Shingles) - Comparative Analysis, H2 2014
  9Number of Products under Development by
  Companies, H2 2014 11Comparative Analysis by
  Late Stage Development, H2 2014 12Comparative
  Analysis by Clinical Stage Development, H2 2014
  13Comparative Analysis by Early Stage
  Development, H2 2014 14Comparative Analysis by
  Unknown Stage Development, H2 2014 15Products
  under Development by Companies, H2 2014 16Herpes
  Zoster (Shingles) - Pipeline by GlaxoSmithKline
  plc, H2 2014 17Herpes Zoster (Shingles) -
  Pipeline by Merck Co., Inc., H2 2014 18

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Herpes Zoster (Shingles), H2 2014 8Number of
  Products under Development for Herpes Zoster
  (Shingles) - Comparative Analysis, H2 2014
  9Number of Products under Development by
  Companies, H2 2014 10Comparative Analysis by
  Clinical Stage Development, H2 2014 13Assessment
  by Monotherapy Products, H2 2014 24Number of
  Products by Top 10 Target, H2 2014 25Number of
  Products by Stage and Top 10 Target, H2 2014
  26Number of Products by Top 10 Mechanism of
  Action, H2 2014 27Number of Products by Stage
  and Top 10 Mechanism of Action, H2 2014 28Number
  of Products by Top 10 Route of Administration, H2
  2014 29

www.aarkstore.com
8
Related Market Research reports

• Corticosteroid-Responsive Dermatoses - Pipeline
  Review, H1 2014
• Hematological Tumor - Pipeline Review, H1 2014
• Inflammation - Pipeline Review, H1 2014
• Opioid Induced Side Effects - Pipeline Review, H1
  2014
• Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports

• Restenosis - Pipeline Review, H1 2014
• Tauopathies - Pipeline Review, H1 2014
• Nasopharyngitis (Common Cold) - Pipeline Review,
  H1 2014
• Mucopolysaccharidosis III (MPS III) (Sanfilippo
  Syndrome) - Pipeline Review, H1 2014
• Chemotherapy Induced Peripheral Neuropathy -
  Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Herpes Zoster (Shingles) - Pipeline
Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com